Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care
Recruiting · NCT06244953 · Interventional (participants receive a specific treatment) · Lead sponsor: National Cancer Centre, Singapore
View the official record on ClinicalTrials.gov →Interventions studied
TIER-HF-PCUsual Care
What this trial is about
There is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this study will assess if TIER-HF-PC is beneficial for patients and caregivers.
Who can take part
Age range
21 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients:
- 21 years or older and
- able to communicate in English/Chinese/Malay and
- be of stage C or D heart failure, as defined by American College of Cardiology/American Heart Association (ACC/AHA) classification system and
- have functional limitation of New York Heart Association (NYHA) functional status of at least 2 or more and
- be deemed by their cardiologist's clinical judgement to have an expected prognosis of at least 6 months survival, and
- have had a heart failure related hospitalization event (e.g. symptomatic decompensated heart failure) within 6 months prior to recruitment and
- have a phone that allows telecommunication.
- Caregivers must meet all the following inclusion criteria to be eligible for the study :
- direct, unpaid, family caregiver of the patient;
- self-reported by the patient to be the main person to be either:
- responsible for up to 4 hours a day of caregiving tasks
- and/or decision maker/spokesperson with the medical team
- Caregiver may or may not live in the same residence as the patient.
- Caregivers must be 21 years and above.
- Able to communicate in English/Chinese/Malay.
Exclusion criteria
- Patients:
- have cognitive impairment (e.g., dementia)
- have severe, untreated, active mental illness (e.g., major depressive disorder)
- have ventricular assist device implant.
- have non-reversible hearing or visual loss or
- are active drug abuser or
- already known to a palliative care service.
- Caregivers who meet any of the exclusion criteria at baseline will be ineligible for the study:
- have cognitive impairment (e.g., dementia) or
- have severe, untreated, active mental illness (e.g., major depressive disorder)
- have non-reversible hearing or visual loss.
- are active drug abuser or
- are a domestic helper for the patient
Where it is running
4 locations listed.
- National Heart Centre Singapore - Singapore, Singapore
- Sengkang General Hospital - Singapore, Singapore
- Khoo Teck Puat Hospital - Singapore, Singapore
- National Cancer Centre, Singapore - Singapore, Singapore